Your browser doesn't support javascript.
loading
Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Assessment of Response to Treatment and Follow-Up in Gastroenteropancreatic Neuroendocrine Neoplasms.
Grimaldi, Franco; Fazio, Nicola; Attanasio, Roberto; Frasoldati, Andrea; Papini, Enrico; Cremonini, Nadia; Davi, Maria V; Funicelli, Luigi; Massironi, Sara; Spada, Francesca; Toscano, Vincenzo; Versari, Annibale; Zini, Michele; Falconi, Massimo; Oberg, Kjell.
Affiliation
  • Grimaldi F; Endocrinology and Metabolic Disease Unit, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
  • Fazio N; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumor, European Institute of Oncology, Milan, Italy.
  • Attanasio R; Endocrinology Service, Galeazzi Institute IRCCS, Milan, Italy.
  • Frasoldati A; Endocrinology Unit, Azienda Ospedaliera S. Maria Nuova IRCCS, Reggio Emilia, Italy.
  • Papini E; Department of Endocrinology and Metabolic Diseases, Regina Apostolorum Hospital, Albano Laziale (Rome), Italy.
  • Cremonini N; Endocrinology Clinics, Clinica Villalba, Bologna, Italy.
  • Davi MV; Section of Endocrinology, Medicina Generale e Malattie Aterotrombotiche e Degenerative, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
  • Funicelli L; Division of Radiology, European Institute of Oncology, Milan, Italy.
  • Massironi S; Gastroenterology and Endoscopy Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
  • Spada F; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumor, European Institute of Oncology, Milan, Italy.
  • Toscano V; Endocrinology, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
  • Versari A; Nuclear Medicine Unit, Azienda Ospedaliera S. Maria Nuova IRCCS, Reggio Emilia, Italy.
  • Zini M; Endocrinology Unit, Azienda Ospedaliera S. Maria Nuova IRCCS, Reggio Emilia, Italy.
  • Falconi M; Division of Pancreatic Surgery, Pancreas Translational and Clinical Research Center, San Raffaele Scientific Institute, Vita e Salute University, Milan, Italy.
  • Oberg K; Department of Endocrine Oncology, University Hospital, Uppsala, Sweden.
Endocr Metab Immune Disord Drug Targets ; 18(5): 419-449, 2018.
Article in En | MEDLINE | ID: mdl-29237387
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Neuroendocrine / Gastrointestinal Neoplasms / Medical Oncology / Antineoplastic Agents Type of study: Etiology_studies / Guideline / Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Endocr Metab Immune Disord Drug Targets Year: 2018 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Neuroendocrine / Gastrointestinal Neoplasms / Medical Oncology / Antineoplastic Agents Type of study: Etiology_studies / Guideline / Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Endocr Metab Immune Disord Drug Targets Year: 2018 Document type: Article